MALAT1 and hepatocellular carcinoma: It has been revealed that this lncRNA is involved in promoting sorafenib resistance in HCC cells and up‐regulated MALAT1 expression is strongly associated with down‐regulated miR‐140‐5p expression, increased Aurora‐A expression and poor outcomes in HCC patients.